RZLT · Rezolute, Inc.
The AI's read
The proceeds can help pay for ersodetug sales preparation and other company needs. That gives Rezolute cash to keep moving toward selling the drug. The new stock means current owners will own a smaller part of Rezolute. The pre-funded warrants can add shares for $0.001 each if exercised, shrinking their portions further. This cost to owners outweighs the benefit of added cash. The sale is expected to close around November 16, subject to customary closing conditions.